R&D Inside out – the coming of age of organ-on-a-chip technology Perhaps the most beautiful thing about pharmacology, and the healthcare industry at large, is the continued pursuit of new ideas and innovations.
Sales & Marketing Global upswing in medical writing, with a bout of M&A Swift pharma R&D growth has accelerated growth of associated industries, like medical writing.
R&D Turning the NHS into a world-leading R&D platform Lord James O'Shaughnessy sets out the basis of his forthcoming independent review.
R&D A look back at RNA Therapeutics – day one The 14th Annual RNA Therapeutics Conference took place in Kensington, London this year.
News Reed pops up at J&J after leaving Sanofi Straight after John Reed's Sanofi exit, he has reappeared as head of pharma R&D at J&J
R&D 6 research and development life science predictions for 2023 From enabling patient choice during clinical trials to strengthening vital partnerships across the quality ecosystem, connected data will become the lifeblood that enables life sciences tea
News Taiho's late-stage Duchenne candidate fails trial Taiho has suffered a blow to its near-term pipeline after a drug candidate for Duchenne muscular dystrophy (DMD) missed the mark in a phase 3 trial.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face